<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02649777</url>
  </required_header>
  <id_info>
    <org_study_id>15-2091</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <nct_id>NCT02649777</nct_id>
  </id_info>
  <brief_title>Normal Values of Oxidative Stress, Taurine, and Related Markers</brief_title>
  <official_title>Normal Values of Oxidative Stress, Taurine, and Related Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The role of oxidative stress in disease pathology is increasingly recognized. At present, the&#xD;
      development of biomarkers of this state is in its infancy and the availability of clinically&#xD;
      validated assays is lacking. This study will better determine normal values for specific&#xD;
      biomarkers of oxidative stress. It will also investigate normal values of taurine, a natural&#xD;
      occurring oxidative stress protectant. A primary and specific application of this data is for&#xD;
      the evaluation of oxidative stress, levels of the natural protectant taurine, and of&#xD;
      associated inflammation in the context of cystathionine β-synthase (ClinicalTrials.gov study:&#xD;
      Oxidative Stress Markers in Inherited Homocystinuria and the Impact of Taurine).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a one-time collection of blood and urine samples in healthy individuals.&#xD;
      Subjects have to be fasting for 3 hours prior to the blood sampling. A maximum of 7.5 mLs of&#xD;
      blood (1 and 1/5 teaspoon) and a urine sample will be collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oxidative stress marker: TBARS</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolite antioxidant: Taurine</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammation marker: Supper oxide dismutase (SOD)</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation marker: TGFβ</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation marker: myeloperoxidase</measure>
    <time_frame>time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolites: S-adenosylmethionine and S-adenosylhomocysteine</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis (same units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular function: Thromboxane B2 metabolites</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis (same units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress: dityrosine</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation markers: IL1α, IL-1β, IL10, TNFα</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis; ELISA assay (same units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation markers: cytokines: IL1α, IL-1β IL-1ra, IL6, IL8, IL17, MCP-1,MIP-1, MIP1α, MIPβ</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis; Luminex assay (same units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation markers: cytokines: TNFα, IL4, IL10 and IL12</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis; high sensitivity Luminex assay (same units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation marker: high sensitivity CRP</measure>
    <time_frame>Time 0</time_frame>
    <description>Single Draw for one-time analysis</description>
  </secondary_outcome>
  <enrollment type="Actual">22</enrollment>
  <condition>Oxidative Stress</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy Individuals older than 8 years and less than 50 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: Over 8 years old and less than 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy: Females who are pregnant or lactating will be excluded from the study as&#xD;
             the influence of pregnancy on the markers is not known nor is the impact of pregnancy&#xD;
             on taurine known.&#xD;
&#xD;
          -  Antioxidant use: Individuals taking taurine, over the counter energy drinks containing&#xD;
             taurine or other high dose antioxidants such as Vitamin C or E, coenzyme Q, carotenes,&#xD;
             selenium will be excluded as such intake will likely impact laboratory results.&#xD;
&#xD;
          -  Inflammatory status:&#xD;
&#xD;
               -  Individuals who have a significant chronic illness or state that has a known or&#xD;
                  suspected marked inflammatory component or oxidative stress component will be&#xD;
                  excluded from the study as the illness will impact inflammatory markers.&#xD;
&#xD;
               -  Patients with an acute illness, which may impact inflammatory biomarkers, will be&#xD;
                  postponed for study entry until the acute illness is resolved. Entry into the&#xD;
                  study at a later day will be offered. The study visit will not be conducted&#xD;
                  within 3 weeks of the acute illness.&#xD;
&#xD;
               -  Smoking within the past 12 months will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan LK Van Hove, MD, PhD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>January 4, 2016</study_first_submitted>
  <study_first_submitted_qc>January 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2016</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oxidative stress</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

